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OBJECTIVE—The effect of diabetes on neovascularization varies
between different organ systems. While excessive angiogenesis
complicates diabetic retinopathy, impaired neovascularization con-
tributes to coronary and peripheral complications of diabetes.
However, how diabetes inﬂuences cerebral neovascularization is
not clear. Our aim was to determine diabetes-mediated changes in
the cerebrovasculature and its impact on the short-term outcome of
cerebral ischemia.
RESEARCH DESIGN AND METHODS—Angiogenesis (capil-
lary density) and arteriogenesis (number of collaterals and intratree
anostomoses) were determined as indexes of neovascularization in
the brain of control and type 2 diabetic Goto-Kakizaki (GK) rats.
The infarct volume, edema, hemorrhagic transformation, and short-
term neurological outcome were assessed after permanent middle–
cerebral artery occlusion (MCAO).
RESULTS—The number of collaterals between middle and ante-
rior cerebral arteries, the anastomoses within middle–cerebral
artery trees, the vessel density, and the level of brain-derived
neurotrophic factor were increased in diabetes. Cerebrovascular
permeability, matrix metalloproteinase (MMP)-9 protein level, and
total MMP activity were augmented while occludin was decreased
in isolated cerebrovessels of the GK group. Following permanent
MCAO, infarct size was smaller, edema was greater, and there was
no macroscopic hemorrhagic transformation in GK rats.
CONCLUSIONS—The augmented neovascularization in the GK
model includes both angiogenesis and arteriogenesis. While adap-
tive arteriogenesis of the pial vessels and angiogenesis at the
capillary level may contribute to smaller infarction, changes in the
tight junction proteins may lead to the greater edema following
cerebral ischemia in diabetes. Diabetes 59:228–235, 2010
T
ype 2 diabetic patients hold two- to fourfold higher
risk for cerebrovascular disease and stroke (1,2),
and 70% of patients with a recent stroke have overt
diabetes or pre-diabetes distinguished by impaired
fasting glucose or impaired glucose tolerance (3). However,
the underlying basis of this increased risk remains unclear.
Diabetic vascular complications are well studied in diabetic
retinopathy, nephropathy, peripheral arterial disease, and
coronary artery disease. However, diabetes-induced struc-
tural and functional changes in the cerebral vasculature are
unknown.
It is becoming clear that the integrity of cerebral blood
vessels is critical in the pathophysiology of stroke. While type
2 diabetes accounts for 90–95% of all diagnosed cases of
diabetes in adult patients, most of the experimental studies
are focused on type 1 diabetes induced by streptozotocin
(STZ) injection, which is associated with high-level and
short-term elevations of blood glucose. We have recently
shown that diabetic Goto-Kakizaki (GK) rats develop smaller
infarct and greater hemorrhagic transformation after stroke.
These animals also showed cerebrovascular remodeling
characterized by increased vessel tortuosity, vascular endo-
thelial growth factor (VEGF) expression, and matrix metal-
loproteinase (MMP)-2 and -9 activity (4). Generated from
glucose-intolerant Wistar rats, GK rat is a nonobese model of
spontaneous type 2 diabetes with moderately elevated glu-
cose levels (5,6). In light of previous reports that showed
greater ischemic damage in acute hyperglycemic models of
stroke (7–9), we hypothesized that chronic moderate hyper-
glycemia as seen in the GK model promotes neovasculariza-
tion that affects the extent of ischemic injury. Considering
that neovascularization may originate from new vessel for-
mation as well as functional remodeling of existing vessels,
the goals of the current study were 1) to determine the effect
of diabetes on capillary density and arteriogenesis, 2)t o
determine the inﬂuence of diabetes on blood-brain barrier
(BBB) baseline permeability and expression of proteins
important for vascular integrity, and ﬁnally 3) to evaluate the
effect of ischemic injury on infarct and hemorrhagic trans-
formation development in diabetic rats with preexisting
vascular disease, all of which may impact the outcome of
ischemic injury.
RESEARCH DESIGN AND METHODS
Male Wistar (Harlan Laboratories, Indianapolis, IN) and GK (in-house bred,
derived from the Tampa colony) rats (10–12 weeks old, 250–270 g) were
maintained at a constant temperature (21–23°C) with a 12/12-h light/dark cycle
and allowed access to food and water ad libitum. Body weight and blood
glucose measurements were performed twice weekly. Glucose measurements
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228 DIABETES, VOL. 59, JANUARY 2010 diabetes.diabetesjournals.orgwere taken from the tail vein and measured using a Free Style glucose meter
(Abbott Diabetes Care, Alameda, CA). A1C was measured to evaluate long-
term glucose levels with an A1C Now
 kit (Bayer Healthcare, Sunnyvale, CA).
Collateral number and size of pial vessels. To determine the effect of
diabetes on the pial vessel arteriogenesis, the collateral number and size of
cerebrovasculature were measured in 5- and 10-week-old animals. After being
anesthetized with sodium pentobarbital (100 mg/kg), the animals were in-
jected with 3 ml freshly prepared polyurethane elastomer PU4ii (vasQtec,
Zurich, Switzerland) through the aorta in 1 min. PU4ii mixture was prepared
by mixing the blue-stained ethylmethylketone (30% of the ﬁnal mixture) and
0.8 g of PU4ii hardener shortly before casting as previously described (10).
The rats were decapitated immediately, and the brain was removed and
immersed in 4% paraformaldehyde for 48 h.
Stereomicroscopic images of the perfused brains were captured, and
actual vessel length of cortical branches of middle cerebral arteries (MCAs)
starting from its origin was measured using National Institutes of Health
Image-J software. Each hemisphere was divided into six grids of equal area,
and the total number of collaterals between the anterior cerebral arteries
(ACAs), posterior arteries (PCAs), and MCAs were counted manually (11). A
collateral was deﬁned as an anastomosis between MCAs and ACAs or PCAs.
Arteriole-to-arteriole anastomoses between the MCA branches were also
counted and deﬁned as intratree anastomosis. The diameter was measured at
the midpoint of the collaterals. At least eight measurements of the diameters
were taken on each hemisphere, and the average of all these measurements
was considered as the average diameter of the collaterals.
Vascular density. Cerebral vessel density was measured with modiﬁed
ﬂuorescein isothiocyanate–dextran assay (12). To stain the vasculature, 1 ml
of 5% FITC-dextran (150 kDa; Sigma, St. Louis, MO) in saline was injected
through the femoral vein and circulated for 30 min under isoﬂurane anesthe-
sia. Brains were enucleated and ﬁxed in 4% paraformaldehyde for 48 h. Brain
sections (50 m) with 600-m intervals were mounted onto slides. By means
of a computer-controlled platform, the hemisphere of the sections was
stereologically captured with the Lucivid system (MicroBrightField, Williston,
VT) and analyzed by the Spaceball protocol of Stereo Investigator software
(13) (MicroBrightField). Each section was randomly counted at 12–18 points,
and the average number was analyzed for statistics. Vessel density was
deﬁned as the length of ﬂuorescence stained capillaries within the observation
area (expressed as m/m
3).
Vascular permeability. The BBB permeability was assessed by measuring
FITC-BSA (Molecular Probes, Carlsbad, CA) extravasations as previously
described (14). In brief, 10 mg/kg FITC-BSA was injected through femoral vein
30 min before the rats were killed. Plasma ﬂuorescence intensity in each
animal was measured with a ﬂuorescence spectrophotometer (BioTek,
Winooski, VT) using standard curves of FITC-BSA in normal rat plasma.
Fluorescence intensity in the cortex of brain sections were analyzed with
a ﬂuorescence microscope (Carl Zeiss, Thronwood, NY). The average cerebral
ﬂuorescence intensity was normalized with the plasma ﬂuorescence intensity
of each animal for statistics.
Isolation of cerebral vessels and evaluation of structural proteins.
After the major vessels (basilar, MCA, ACA, PCA, and connecting arteries of
the Circle of Willis) were removed and saved as macrovessel preparation, the
brain was homogenized with ice-cold PBS (0.01mmol/l, pH 7.4). The homog-
enate was centrifuged at 2,000g, 4°C for 10 min. The supernatant was saved as
brain homogenate (15). The pellet was washed in PBS and gently layered on
top of a dextran solution (15%, MW 38,400) and centrifuged at 4,000g, 4°C for
20 min. The ﬁnal pellet was saved as cerebral microvessel preparation. Both
macro- and microvessels were homogenized in radioimmunoprecipitation
buffer as previously described (16). Homogenates were immunoblotted with
occludin and claudin-5 (Zymed Laboratories, Carlsbad, CA), collagen IV
(Abcam, Cambridge, MA), MMP-2, and MMP-9 (Calbiochem, Gibbstown, NJ)
antibodies, respectively. All blots were probed with actin (Calbiochem) for
loading control. Densities of protein bands were analyzed with Gel Pro
Analyzer software (Media Cybernetics, Bethesda, MD). Total MMP activities
were measured in macrovessels with gelatin zymography as previously
described (16). Brain-derived neurotrophic factor (BDNF) level in the homog-
enates was measured using an enzyme-linked immunosorbent assay (ELISA)
kit from Promega (Madison, WI).
Focal cerebral ischemia. The unilateral permanent MCAO was achieved by
intraluminal ﬁlament technique (4,17). The animals were anesthetized with
isoﬂuorane inhalation in a glass chamber prior to stroke procedure. The right
femoral artery was catheterized for blood sampling for arterial blood gas
analysis. The anesthesia was kept at 2% isoﬂuorane in 70% nitrous oxide and
30% oxygen during surgery. The cerebral perfusion was measured with a PIM
3 scanning laser Doppler imaging system (Perimed, Stockholm, Sweden) to
evaluate basal perfusion as well as changes in perfusion following MCAO to
conﬁrm successful occlusion. Body temperature was maintained constant at
37.5°C with a heating pad and monitored by a rectal probe.
At 24 h after occlusion, cerebral blood perfusion was evaluated with PIM
3 again and the animal was immediately killed. Brains were enucleated and
sliced in the coronal plane with 2-mm intervals. Section images were scanned
before and after 2,3,5-triphenyltetrazolium chloride (TTC) staining. The in-
farct size was evaluated as previously described (4). Hemorrhagic transfor-
mation was assessed macroscopically in a binary fashion since our previous
study showed overt hematoma formation but not diffuse bleeding in GK rats.
Edema was determined as the difference in volume of ischemic and nonisch-
emic hemispheres and normalized to infarct volume.
Neurobehavioral tests. Neurological outcome of ischemic injury was as-
sessed by a Bederson test (16) and elevated-body swing test (EBST). The
Bederson test was combined with contralateral hind-limb retraction, beam
walking ability, and bilateral forepaw grasp tests (18). Scores were given to
each item from 0 to 3 for a total of 12 for maximal deﬁcit. The animals with
a score lower than six after MCAO were excluded for analysis. These tests
were repeated at 24 h before the animals were killed. EBST was assessed to
evaluate motor asymmetry (19).
Statistical analysis. A two-tailed unpaired t test, 95% CI, was used to
compare the average data for all the studies between two groups. Data are
expressed as means  SE. Differences were considered signiﬁcant at P  0.05.
RESULTS
Physiological parameters. Metabolic parameters are sum-
marized in Table 1. A1C and blood glucose was signiﬁcantly
higher in diabetic animals. There was no signiﬁcant differ-
ence in arterial blood gases and body weight.
Effect of diabetes on cerebral neovascularization.
Neovascularization may result from angiogenesis (capil-
lary sprouting) and/or arteriogenesis (collateral formation
and growth as a result of remodeling of native collaterals
to functional arterioles). Number and diameter of collat-
erals formed between pial MCAs and ACAs were evaluated
as measures of arteriogenesis. In addition, number of
anostomoses within the MCA tree was determined. Visu-
alization of the surface vasculature demonstrated that
cerebral vessels display increased tortuosity and typical
corkscrew pattern in 10-week-old GK rats as we previously
reported (Fig. 1). Diabetes signiﬁcantly improved the
number (Fig. 1E) and diameter (Fig. 1F) of the collaterals
and intratree arteriole-to-arteriole anastomoses (Fig. 1G)
between MCA branches. To determine whether these
changes are inherent to the GK model or develop as a
result of diabetes, we evaluated collateral numbers in
younger (5-week-old) control and GK rats before the onset
of diabetes and no difference was found between the
groups (Fig. 1E). Capillary density was measured as an
index of angiogenesis. There was prominent microvessel
stained with FITC-dextran and the quantiﬁcation using
unbiased stereological analysis with the Spaceball proto-
col in Stereo Investigator software demonstrated in-
creased capillary density in diabetic animals (Fig. 1H).
Effect of diabetes on cerebrovascular integrity. Since
there was an increase in capillary density, in order to determine
whether the vascular structure alterations induced by diabetes
contribute to increased leakiness, the BBB permeability was
TABLE 1
Physiological parameters of control and diabetic rats in the study
Control Diabetes
n 12 9
Body weight (g) 262  6 255  8
Blood glucose (mg/dl) 106  3 145  6*
A1C (%) 4.6  0.1 7.3  0.7*
pH 7.44  0.01 7.39  0.06
pCO2 (mmHg) 44.7  0.8 49.1  6.6
pO2 (mmHg) 168  5 159  4
Data are means  SE. *P  0.0001 vs. control.
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fold increase in ﬂuorescence intensity in diabetes compared
with control indicating increased baseline permeability in dia-
betes (Fig. 2A). Next, tight junction proteins occludin and
claudin-5 as well as collagen IV, a key component of basal
lamina, were measured in cerebral micro and macrovessels
isolated from control and diabetic animals. A 65-kDa band
corresponding to occludin was detected in all samples and it
was decreased in the microvasculature of diabetic animals as
compared with controls (Fig. 2B). There was no difference in
occludin levels in the macrovessels. A lower band around 63
kDa was also detected in both vascular beds with no difference
between groups (data not shown). Claudin-5 and collagen IV
levels were similar in micro- and macrovessels from both
experimental groups (Figs. 2C and D).
MMPs are involved in the regulation of vascular remod-
eling and BBB breakdown following ischemic injury. Thus,
MMP-2 and MMP-9 proteins were measured in the same
macro- and microvessel preparations used for evaluation
of tight junction proteins. MMP-9 was more abundant in
both micro- and macrovessels from diabetic GK rats than
in controls (Fig. 3A). MMP-2, on the other hand, was
signiﬁcantly higher in the macrovessels, but not microves-
sels, of diabetic rats (Fig. 3B). MMP-2 and MMP-9 activity
of macrovessels was assessed by gelatin zymography.
Despite increases in MMP-2 protein levels in diabetic rats,
there was no difference in MMP-2 activity between control
and GK rats. MMP-9 activity, on the other hand, was
increased in diabetic rats. Microvessel MMP-2 activity was
also similar between groups (data not shown). Lytic bands
corresponding to microvessel MMP-9 were very faint, so
they were not quantiﬁed. To determine whether increased
MMP activities were developed as a result of diabetes, we
also measured macrovessel MMP activities in 5-week-old
rats before the onset of diabetes. Total MMP activities
were 108  15 vs. 99  11 pixels in control and diabetic
rats (n  4), respectively.
A recent study (20) provided evidence that BDNF re-
leased from endothelial cells protects the neurons from a
wide array of insults. Accordingly, BDNF levels in the
vessel preparations were measured by ELISA. The mac-
rovessels of both control and diabetic animals showed
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FIG. 1. Increased angiogenesis and arteriogenesis in diabetic GK rats. A–D: Representative brain images of 10-week-old control (A and B, n  9)
and diabetic GK (C and D, n  7) rats infused with Pu4ii indicate increased vascular tortuosity (corkscrew pattern) indicative of vascular
remodeling and collateralization in diabetes. Arrow: collaterals between MCA and PCA or ACA; arrow head: anastomoses between MCA branches.
E: Number of collaterals was signiﬁcantly increased in 10-week-old GK rats compared with control but not in younger 5-week-old animals (n 
5 per group) before the onset of diabetes. In 10-week-old animals, the diameter of the collaterals (F), the anastomoses within the MCA tree (G),
and the total microvessel density (H) were all increased in diabetes (n  6 per group). *P < 0.05 vs. control. , 5 weeks; f, 10 weeks. (A
high-quality color digital representation of this ﬁgure is available in the online issue.)
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group had higher level than controls (Fig. 3D).
Infarct size, hemorrhagic transformation, and edema.
Infarct size was smaller (29%) in diabetic animals than in
controls (49%) (Fig. 4A). Consistent with our previous ﬁnd-
ings, the infarcts were mainly in the striatum in GK rats,
while that of Wistar rats had both cortical and subcortical
localization. Edema on the other hand was higher in diabetes
(Fig. 4B). In contrast to our previous ﬁnding of overt hema-
toma formation following3hM CAO/21 h reperfusion (4),
there was no macroscopic hemorrhagic transformation after
24 h permanent MCAO in either strain.
Neurobehavioral outcome. The modiﬁed Bederson test
score was 0 in both groups before surgery and increased to
10.8  0.3 in control and to 9.7  0.4 in diabetic rats at 24 h
after MCAO (Fig. 4C). As shown in Fig. 4D, MCAO induced
a signiﬁcant increase in left-swing responses in both
groups with no obvious difference between the groups.
Cerebral perfusion. Single-point laser Doppler probe has
been widely used at monitoring cerebral blood perfusion
in MCAO experiments. However, the single-point blood
ﬂow alteration is less representative for the overall perfu-
sion. In this study, we used the scanning laser Doppler
imaging system to monitor the real time subcranial cere-
bral blood perfusion. At 5 min after MCAO, the extent of
perfusion decrease was similar in both control and dia-
betic rats (Fig. 5A), indicating that the extent of occlusion
was comparable between the groups. However, at 24 h and
immediately before they were killed, GK rats showed a
slight recovery of perfusion, whereas there was no change
in control rats (Fig. 5B).
DISCUSSION
Both clinical and experimental studies have shown that
elevations in blood glucose due to preexisting diabetes or
the acute stress response at the time of stroke is associ-
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FIG. 2. Cerebrovascular permeability and matrix proteins are altered in diabetic GK rats. A: BBB permeability was signiﬁcantly increased in
diabetes (n  6 per group). *P < 0.01. B: Occludin protein levels, evaluated by immunoblotting of brain microvessel and macrovessel homogenates
and normalized to actin levels, were decreased in the microvasculature of diabetic rats (n  8 per group). *P < 0.05 vs. control. There was no
difference in microvessels or microvessel claudin-5 levels (C) or microvascular collagen IV levels (D) in control and diabetic animals (n  8 per
group). , microvessel; f, macrovessel.
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infarction and an increased risk of hemorrhagic transfor-
mation secondary to acute ischemic stroke (21–26). The
emerging neurovascular unit concept underlies the impor-
tant contribution of cerebral blood vessels to the patho-
physiology of stroke (27). Diabetes, although endocrine in
origin, increases mortality and morbidity due to its vascu-
lar complications. It is a well-established fact that adaptive
neovascularization of the coronary and peripheral circula-
tions is impaired in diabetes, resulting in increased coro-
nary artery disease and peripheral vascular disease risk,
respectively (28,29). On the other hand, excessive angio-
genesis occurs in the retinal circulation leading to diabetic
retinopathy. The effect of diabetes on cerebral vasculature
was unknown. Accordingly, this study investigated the
early effects of diabetes (5-week period) on cerebrovascu-
lar density, neovascularization patterns, permeability, and
perfusion in a type 2 diabetes model that presents with
increased vascular but decreased neuronal damage follow-
ing I/R injury (4). The main ﬁndings are 1) cerebrovascular
density and collateralization was increased in diabetic rats
providing evidence of increased angiogenesis and arterio-
genesis; 2) BBB integrity was compromised even before
an ischemic insult in diabetes; 3) 24 h after permanent
occlusion, there was small but signiﬁcant recovery of
perfusion in diabetic rats, suggesting collateral ﬂow; 4)
consistent with our previous results with temporary
MCAO, permanent occlusion also caused smaller infarcts
in diabetes, suggesting neuroprotection in early moderate
diabetes; and 5) there was no macroscopic hemorrhage
after permanent occlusion, suggesting that bleeding is
result a reperfusion injury of the newly formed/remodeled
vessels in this model.
In contrast to previous reports that hyperglycemia pro-
motes infarct expansion as mentioned above, we have
reported smaller infarction but greater and more frequent
hemorrhagic transformation occurrence in GK rats, a lean
model of type 2 diabetes, after ischemic reperfusion injury
induced by3hM C A Oa n d2 1hreperfusion (4). It was also
observed that cerebrovascular tortuosity and MMP activity
in MCA were increased prior to I/R injury, providing
evidence for cerebrovascular remodeling after a short 5- to
6-week period of diabetes as GK rats develop diabetes
around 6 weeks of age and MCAO was performed when
animals were 11–12 weeks old. These results suggested
that there may be vascular and neuronal components
contributing to differences observed in patterns of isch-
emic injury in control versus diabetic rats. Thus, the
current study focused on early changes induced by diabe-
tes on the cerebrovasculature from a structural point of
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FIG. 3. Effect of diabetes on extracellular matrix proteins and BDNF levels. MMP proteins are differentially regulated in the cerebrovasculature
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CEREBRAL NNEOVASCULARIZATION IN TYPE 2 DIABETES
232 DIABETES, VOL. 59, JANUARY 2010 diabetes.diabetesjournals.orgview. It is well established that diabetes modulates neo-
vascularization depending on the vascular bed. While
excessive pathological angiogenesis leads to diabetic ret-
inopathy (28,30), neovascularization is impaired in the
myocardium and skeletal muscle contributing to coronary
artery disease and peripheral arterial disease, respectively.
Accordingly, we ﬁrst addressed the question whether
there was neovascularization in diabetic rats. Neovascu-
larization may result from vasculogenesis (new vessel
formation from progenitor cells), angiogenesis (capillary
sprouting), collateral growth, and/or arteriogenesis de-
ﬁned as remodeling of native collaterals to functional
arterioles (31–33). As the vessels remodel and collaterals
form, vessels present with increased diameter and a
typical corkscrew pattern as we detect in the pial vessels
of the GK model (34). Accordingly, we evaluated capillary
density as a measure of angiogenesis and pial collateral
number and diameter as a measure of arteriogenesis in our
model, all of which were increased in diabetes. These
ﬁndings suggest that cerebrovasculature undergoes adap-
tive arteriogenesis and angiogenesis in moderate diabetes.
We next evaluated permeability as a measurement of cere-
brovascular integrity in diabetes prior to an ischemic event.
Increased permeability may be due to diabetes-induced damage
to the BBB function and/or due to the immature nature of the
newly formed vessels. Cerebrovascular permeability was in-
creased in diabetes as reported in early diabetic retinopathy
(14,35). Since tight junction proteins such as occludin and
claudin-5 have essential roles in regulating BBB stability (36),
we evaluated abundance of occludin, claudin-5, and collagen IV
in the isolated micro- and macrovascular vessels from the brain.
Occludin was lower in the microvasculature but not macrovas-
culature of the diabetic group. Chehade et al. (37) reported that
occludin but not zona occludens-1 levels are decreased at 2
weeks after the induction of diabetes by STZ injection. Another
study reported increased MMP-2 and MMP-9 activity and rapid
degradation of occludin after temporary focal ischemia (38). In
the current study, MMP-9 was increased in microvessel prepa-
ration along with decreased occludin. Taken together, these
changes in the structural components of microvessels may be
contributing to increased permeability in the diabetic GK rats.
While we do not have direct evidence on the regulation of these
proteins following an ischemic insult in our model, it is highly
possible that these changes also play a role in the development
of increased edema formation following permanent focal
MCAO as we report in the current study as well as the
development of overt hematomas following temporary occlu-
sion in the GK rats as we reported previously (4).
Cerebral perfusion is a key determinant of the extent of
ischemic injury. Thus, we conﬁrmed that the extent of
MCA occlusion was similar in control and diabetic rats
using a scanning-laser Doppler imaging system. While it is
recognized that cerebral blood ﬂow needs to be assessed
by more quantitative approaches, we found that 24 h after
permanent MCAO, there was restoration of cerebral per-
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FIG. 4. Infarct size is smaller in diabetic rats after permanent MCAO. A: Summary of cerebral infarct size from TTC-stained brain sections of
control and diabetic rats. Infarct size was calculated as percentage of contralateral hemisphere (n  13 for control and 9 for diabetes). *P 
0.001. B: Edema formation was assessed as the volume difference between ischemic and nonischemic hemispheres and normalized to infarct
volume. *P < 0.05. There was a small but signiﬁcant difference in Bederson score (C) but not in EBST (D) between the groups. *P < 0.05. D: ,
before; f, after. (A high-quality color digital representation of this ﬁgure is available in the online issue.)
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collateralization in GK rats.
Numerous past experimental studies have reported
exacerbation of the ischemic damage by hyperglycemia
(7,21,24,25,39). These studies also reported increased hem-
orrhagic transformation only if blood ﬂow was reestablished
following occlusion. Consistent with these results, in the
current study we did not observe any hematoma formation in
either group. The interesting ﬁnding of the current study is
consistent with our previous ﬁnding that infarct size is
smaller in diabetic GK rats even after permanent occlusion.
Careful review of the literature on diabetes and focal brain
ischemia demonstrated that most studies used animal mod-
els in which blood glucose was elevated acutely by glucose
injection just prior to occlusion or diabetes was induced by
STZ injection a few days prior to surgery. In leptin receptor–
deﬁcient db/db mice, edema and infarct size after hypoxic-
ischemic injury was increased as compared with nondiabetic
animals (40), but it has to be recognized that this model is
associated with obesity, and leptin is neuroprotective. An
earlier study by Warner et al. reported that acutely hypergly-
cemic, but not diabetic, rats are more vulnerable to global
ischemia despite similar levels of glycemia, suggesting some
degree of protection in diabetes (41). Observational studies
support this concept. Hyperglycemic nondiabetic acute isch-
emic stroke patients appear to suffer the most from stroke
(26,42). Interestingly, myocardium is reported to be resistant
to ischemic injury in diabetes as a result of metabolic
preconditioning (43). We detected higher BDNF levels in the
vessels of diabetic rats. A recent in vitro study (20) provided
very intriguing evidence for neuroprotection by endothelium-
derived BDNF secretion mediated by integrin signaling. It is
possible that in our model, all the neovascularization events
taking place may stimulate BDNF synthesis and release.
Based on our intriguing results, we speculate that longer
duration of hyperglycemia as seen in our GK model precon-
ditions the brain, although mechanisms by which this occurs
remain to be determined.
There are limitations to our study. First of all, the GK
rats are a model of moderate type 2 diabetes without
confounding factors like obesity and dyslipidemia that are
frequently found in stroke patients. Howewer, diabetes is
a risk factor for stroke independent of these comorbidi-
ties, and thus GK rats allow us to study effects of hyper-
glycemia alone. GK rats are an in-bred strain, and vascular
changes may be inherent to the model. However, the fact
that there was no difference in collateral numbers and
MMP activity in younger GK rats before the onset of
diabetes as compared with control rats at that age argues
against this possibility. We also used relatively young
animals. As with any animal model of disease, the diversity
of acute ischemic stroke patients in clinical setting cannot
be replicated with this model. Second, this study included
only a short-term functional evaluation after stroke.
Edema and microvascular responses may still be evolving
at this point and functional recovery at later time points
need to be assessed. Finally, we only studied the effect of
short and moderate elevations in blood glucose, but dura-
tion and degree of hyperglycemia in diabetes may be
critical for neurovascular outcomes following ischemic
injury. Nevertheless, our results provide direct evidence
that diabetes alters cerebrovascular density, neovascular-
ization patterns, and microvascular permeability, all of
which affect the neuronal and vascular damage following
ischemic brain injury. When compared with the literature,
these ﬁndings also suggest that the pattern of ischemic
injury under diabetic and hyperglycemic conditions dif-
fers. Given that therapeutic angiogenesis after stroke is an
active area of research, an enhanced understanding of
cerebrovascular networking in the setting of diabetes is
fundamentally important to develop preventive and thera-
peutic strategies for stroke in high-risk patients as well as
improving therapeutic angiogenesis after stroke. The
effect of longer duration of diabetes on cerebrovascular
function, structure, and ultimately on ischemia/reperfu-
sion injury requires further study.
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